Stratification into groups with high and low TMB revealed other cancers where CDK8 expression became a marker of shorter OS only in tumors with low TMB, namely melanoma, ovarian adenocarcinoma and renal clear cell carcinoma (Figure 8). Here, CDK8 is linked to clear cell renal carcinoma.